World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
16216
World Ranking
2514
National Ranking
217

Overview

Richard Szydlo is affiliated with Imperial College London in the United Kingdom. Their research activity is primarily situated within the field of Medicine, with a focused expertise in Hematology and related subfields including Molecular Biology, Surgery, Genetics, and Immunology.

The main topics of their work encompass chronic myeloid leukemia treatments, hematopoietic stem cell transplantation, COVID-19 clinical research studies, long-term effects of COVID-19, RNA modifications and cancer, mechanical circulatory support devices, and chronic lymphocytic leukemia research.

Frequent publication venues for Szydlo include Blood, British Journal of Haematology, Bone Marrow Transplantation, eJHaem, and Zenodo (CERN European Organization for Nuclear Research).

They have collaborated extensively with several researchers, including Michael Laffan, Deepa J. Arachchillage, Dragana Milojković, Andrew J. Innes, and Aristeidis Chaidos.

Recent papers authored or co-authored by Szydlo include:

  • Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia, 2021, Science Translational Medicine
  • Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients, 2020, Haematologica
  • Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study, 2021, British Journal of Haematology
  • TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia, 2020, British Journal of Haematology
  • Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact, 2021, Immunotherapy Advances

Best Publications

  • Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

    David Marin;Alexandra Bazeos;Francois Xavier Mahon;Lina Eliasson

  • Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis

    Hugues de Lavallade;Jane F. Apperley;Jamshid S. Khorashad;Dragana Milojkovic

  • Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

    David Marin;Amr R. Ibrahim;Claire Lucas;Gareth Gerrard

  • Results of Allogeneic Bone Marrow Transplants for Leukemia Using Donors Other Than HLA-Identical Siblings

    R Szydlo;J M Goldman;J P Klein;R P Gale

  • Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

    Francesco Dazzi;R. M. Szydlo;C. Craddock;N. C. Cross

  • Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy.

    Amr R Ibrahim;Lina Eliasson;Jane F Apperley;Dragana Milojkovic

  • Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

    Francesco Dazzi;Richard M. Szydlo;Nicholas C P Cross;C. Charles Craddock

  • Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

    Charles Crawley;Marc Lalancette;Richard Szydlo;Maria H Gilleece

  • Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    F van Rhee;R M Szydlo;J Hermans;A Devergie

  • Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

    Eduardo Olavarria;Edward Kanfer;Richard Szydlo;Jaspal Kaeda

  • Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression

    Jamshid S. Khorashad;Hugues de Lavallade;Jane F. Apperley;Dragana Milojkovic

  • Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase

    John M. Goldman;Richard Szydlo;Mary M. Horowitz;Robert Peter Gale

  • The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia

    Mohamad Mohty;Agnes S. M. Yong;Richard M. Szydlo;Jane F. Apperley

  • Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

    Aristeidis Chaidos;Scott Patterson;Richard Szydlo;Mohammed Suhail Chaudhry

  • Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

    Jaspal Kaeda;Derville O'Shea;Derville O'Shea;Richard M. Szydlo;Richard M. Szydlo;Eduardo Olavarria;Eduardo Olavarria

  • Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand

    Francesco Dazzi;Richard M Szydlo;John M Goldman

  • Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

    Dragana Milojkovic;Emma Nicholson;Jane F Apperley;Tessa L Holyoake

  • Three decades of transplantation for chronic myeloid leukemia: what have we learned?

    Jiri Pavlu;Richard M Szydlo;John M Goldman;Jane F Apperley

  • Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response.

    Edward D. Seaton;Richard M. Szydlo;Edward Kanfer;Jane F. Apperley

  • Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis.

    C. Craddock;R. M. Szydlo;Francesco Dazzi;E. Olavarria

  • Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.

    Hugues de Lavallade;Paula Garland;Takuya Sekine;Katja Hoschler

  • Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party.

    A. J. Barrett;F. Locatelli;J. G. Treleaven;A. Gratwohl

Frequent Co-Authors

Jane F. Apperley
Jane F. Apperley Imperial College London
John M. Goldman
John M. Goldman Imperial College London
Francesco Dazzi
Francesco Dazzi King's College London
Irene Roberts
Irene Roberts University of Oxford
Charles Craddock
Charles Craddock Queen Elizabeth Hospital Birmingham
Nigel H. Russell
Nigel H. Russell University of Nottingham
Katayoun Rezvani
Katayoun Rezvani The University of Texas MD Anderson Cancer Center
Nicholas C.P. Cross
Nicholas C.P. Cross University of Southampton
Michael Laffan
Michael Laffan Imperial College London
Steven G.E. Marsh
Steven G.E. Marsh University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare fields like Nurse Practitioner roles offer promising career options. Many students seek the cheapest psychiatric nurse practitioner programs to maximize education affordability while gaining specialized skills in mental health care.

Understanding compensation is important in career planning. The dnp salary transparency resource provides clear data on Doctor of Nursing Practice earnings by state, helping candidates make informed decisions about where to work after graduation.

Professional growth often involves transitions between specialties. For example, transitioning from a Family Nurse Practitioner to an Acute Care NP can be facilitated through a fnp to acute care np bridge program, which offers a tailored curriculum for advancing clinical expertise and expanding career options within immunology-related fields.

For those seeking faster entry into the workforce, accelerated nurse practitioner programs present an efficient pathway to obtain the necessary credentials while balancing other commitments through online study options.

Best Scientists Citing Richard Szydlo

Trending Scientists

Recently Published Articles